# Bioequivalence Study of 4 mg Glimepiride Tablet

> **NCT01677247** · NA · COMPLETED · sponsor: **Dexa Medica Group** · enrollment: 24 (actual)

## Conditions studied

- Glimepiride BE Study in Healthy Volunteers Under Fasting Condition

## Interventions

- **DRUG:** Group I (Test) : Glimepiride 4 mg tablet of PT Dexa Medica
- **DRUG:** Group II (Reference) : glimepiride (Amaryl) 4 mg tablet of PT Sanofi Aventis

## Key facts

- **NCT ID:** NCT01677247
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01677247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01677247, "Bioequivalence Study of 4 mg Glimepiride Tablet". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01677247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*